• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞计数:非酒精性脂肪性肝病的一个未被认识到的危险因素。

Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.

机构信息

Department of Endocrinology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, China.

出版信息

Front Endocrinol (Lausanne). 2021 Dec 7;12:760981. doi: 10.3389/fendo.2021.760981. eCollection 2021.

DOI:10.3389/fendo.2021.760981
PMID:34950103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8688742/
Abstract

OBJECTIVE

Nonalcoholic fatty liver disease (NAFLD) is becoming a global public health challenge. A convenient NAFLD indicator will greatly facilitate risk appraisal and prevention. As a readily available and inexpensive hematological index in routine clinical examinations, red blood cells (RBCs) are gaining increasing attention in many diseases, such as metabolic syndrome, but their association with NAFLD is unknown.

METHODS

This health management cohort study included 27,112 subjects (17,383 non-NAFLD and 9,729 NAFLD) with up to 5 years of follow-up (median 2.8 years). NAFLD was diagnosed by ultrasonography. NAFLD severity was categorized as mild, moderate, or severe. The generalized estimation equation (GEE), an extension of generalized linear models that allows for analysis of repeated measurements, was used to analyze the association between RBC count and NAFLD.

RESULTS

Overall, 4,332 of 17,383 (24.9%) subjects without NAFLD at baseline developed NAFLD. Incident NAFLD risk was positively associated with RBC count. After adjustment for hemoglobin and other confounders, the risk of incident NAFLD was 21%, 32%, and 51% higher in the second, third, and fourth RBC count quartiles, respectively, than in the lowest quartile. In 1,798 of 9,476 (19.0%) subjects with NAFLD at baseline, the severity of NAFLD increased. NAFLD progression risk increased progressively as RBC count increased (P for trend < 0.001). Every one-unit (10 cells/L) increase in RBC count was associated with a 53% [OR 1.53 (95% CI 1.32-1.77)] increased risk for NAFLD progression.

CONCLUSIONS

Elevated RBC count was independently associated with a high risk of NAFLD incidence and progression. This finding revealed a convenient NAFLD risk indicator.

摘要

目的

非酒精性脂肪性肝病(NAFLD)正在成为全球公共健康挑战。一个方便的 NAFLD 指标将极大地方便风险评估和预防。红细胞(RBC)作为常规临床检查中一种现成且廉价的血液学指标,在许多疾病中,如代谢综合征中,越来越受到关注,但它们与 NAFLD 的关系尚不清楚。

方法

这项健康管理队列研究纳入了 27112 名受试者(17383 名非 NAFLD 和 9729 名 NAFLD),随访时间长达 5 年(中位数 2.8 年)。NAFLD 通过超声诊断。将 NAFLD 严重程度分为轻度、中度和重度。广义估计方程(GEE)是广义线性模型的扩展,允许对重复测量进行分析,用于分析 RBC 计数与 NAFLD 之间的关联。

结果

在基线时没有 NAFLD 的 17383 名受试者中,共有 4332 名(24.9%)发展为 NAFLD。新发 NAFLD 风险与 RBC 计数呈正相关。在校正血红蛋白和其他混杂因素后,RBC 计数处于第二、第三和第四 quartile 的新发 NAFLD 风险分别比最低 quartile 高 21%、32%和 51%。在基线时有 NAFLD 的 9476 名受试者中,有 1798 名(19.0%)NAFLD 严重程度增加。随着 RBC 计数的增加,NAFLD 进展风险逐渐增加(趋势 P<0.001)。RBC 计数每增加一个单位(10 个细胞/L),NAFLD 进展的风险增加 53%[比值比 1.53(95%置信区间 1.32-1.77)]。

结论

升高的 RBC 计数与 NAFLD 发病和进展的高风险独立相关。这一发现揭示了一个方便的 NAFLD 风险指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/f1c9e8a1c8c1/fendo-12-760981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/eccbbe942027/fendo-12-760981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/7542573e6b0d/fendo-12-760981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/897fcc46b0c1/fendo-12-760981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/f1c9e8a1c8c1/fendo-12-760981-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/eccbbe942027/fendo-12-760981-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/7542573e6b0d/fendo-12-760981-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/897fcc46b0c1/fendo-12-760981-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4486/8688742/f1c9e8a1c8c1/fendo-12-760981-g004.jpg

相似文献

1
Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease.红细胞计数:非酒精性脂肪性肝病的一个未被认识到的危险因素。
Front Endocrinol (Lausanne). 2021 Dec 7;12:760981. doi: 10.3389/fendo.2021.760981. eCollection 2021.
2
High red blood cell distribution width is closely associated with nonalcoholic fatty liver disease.高红细胞分布宽度与非酒精性脂肪性肝病密切相关。
Eur J Gastroenterol Hepatol. 2014 Feb;26(2):174-8. doi: 10.1097/MEG.0b013e328365c403.
3
Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.血红蛋白联合甘油三酯和铁蛋白预测非酒精性脂肪肝
J Gastroenterol Hepatol. 2014;29(7):1508-14. doi: 10.1111/jgh.12580.
4
Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.年龄相关的骨骼肌量减少是发生非酒精性脂肪性肝病的独立危险因素:一项 10 年回顾性队列研究。
Gut Liver. 2019 Jan 15;13(1):67-76. doi: 10.5009/gnl18070.
5
Elevated Hemoglobin Level Is Associated With Advanced Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease.血红蛋白水平升高与儿童非酒精性脂肪性肝病的晚期纤维化相关。
J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):150-155. doi: 10.1097/MPG.0000000000001614.
6
Decreased lung function is associated with risk of developing non-alcoholic fatty liver disease: A longitudinal cohort study.肺功能下降与非酒精性脂肪性肝病发病风险的相关性:一项纵向队列研究。
PLoS One. 2019 Jan 23;14(1):e0208736. doi: 10.1371/journal.pone.0208736. eCollection 2019.
7
Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.非酒精性脂肪性肝病瘦患者的特征:高血红蛋白水平的潜在作用。
Scand J Gastroenterol. 2015 Mar;50(3):341-6. doi: 10.3109/00365521.2014.983160. Epub 2014 Dec 26.
8
Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.血清尿酸与非肥胖中国成年人的非酒精性脂肪肝。
Lipids Health Dis. 2017 Oct 16;16(1):202. doi: 10.1186/s12944-017-0531-5.
9
New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.新的非酒精性脂肪性肝病和纤维化进展与慢性肾脏病发病风险相关。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3957-e3968. doi: 10.1210/clinem/dgab425.
10
A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease.一项关于幽门螺杆菌感染与非酒精性脂肪性肝病相关性的队列研究。
J Gastroenterol. 2017 Nov;52(11):1201-1210. doi: 10.1007/s00535-017-1337-y. Epub 2017 Apr 5.

引用本文的文献

1
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis.血细胞计数与非酒精性脂肪性肝病:孟德尔随机化分析证据
World J Hepatol. 2024 Aug 27;16(8):1145-1155. doi: 10.4254/wjh.v16.i8.1145.
2
Effects of a Two-Year Lifestyle Intervention on Intrahepatic Fat Reduction and Renal Health: Mitigation of Inflammation and Oxidative Stress, a Randomized Trial.一项为期两年的生活方式干预对肝内脂肪减少和肾脏健康的影响:减轻炎症和氧化应激,一项随机试验
Antioxidants (Basel). 2024 Jun 21;13(7):754. doi: 10.3390/antiox13070754.
3
A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank.

本文引用的文献

1
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach.非酒精性脂肪性肝病:一种需要多学科和整体方法的多系统疾病。
Lancet Gastroenterol Hepatol. 2021 Jul;6(7):578-588. doi: 10.1016/S2468-1253(21)00020-0. Epub 2021 May 4.
2
Severity of Nonalcoholic Fatty Liver Disease and Risk of Future Ischemic Stroke Events.非酒精性脂肪性肝病严重程度与未来缺血性卒事件风险的关系。
Stroke. 2021 Jan;52(1):103-110. doi: 10.1161/STROKEAHA.120.030433. Epub 2020 Dec 4.
3
Sex-related aspects of the red blood cell storage lesion.
高网织红细胞计数是代谢功能障碍相关脂肪性肝病发病的危险因素:对英国生物银行310,091名个体数据的横断面和前瞻性研究。
Front Pharmacol. 2024 Jul 1;15:1281095. doi: 10.3389/fphar.2024.1281095. eCollection 2024.
4
Impact of Adherence to the Mediterranean Diet on Antioxidant Status and Metabolic Parameters in NAFLD Patients: A 24-Month Lifestyle Intervention Study.坚持地中海饮食对非酒精性脂肪性肝病患者抗氧化状态和代谢参数的影响:一项为期24个月的生活方式干预研究。
Antioxidants (Basel). 2024 Apr 17;13(4):480. doi: 10.3390/antiox13040480.
5
Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff.医院工作人员中代谢相关脂肪性肝病的患病率及危险因素
Diabetes Metab Syndr Obes. 2023 Apr 27;16:1221-1234. doi: 10.2147/DMSO.S407657. eCollection 2023.
6
Associations between red blood cell count and metabolic dysfunction-associated fatty liver disease(MAFLD).红细胞计数与代谢相关脂肪性肝病(MAFLD)之间的关联。
PLoS One. 2022 Dec 27;17(12):e0279274. doi: 10.1371/journal.pone.0279274. eCollection 2022.
7
Health associations of liver enzymes and inflammatory scores with urinary citrus flavonoid metabolites.肝脏酶和炎症评分与尿中柑橘类黄酮代谢物的健康关联。
Food Funct. 2023 Jan 23;14(2):1011-1023. doi: 10.1039/d2fo02846h.
8
Mechanisms Underlying Antipsychotic-Induced NAFLD and Iron Dysregulation: A Multi-Omic Approach.抗精神病药物诱发非酒精性脂肪性肝病和铁代谢失调的潜在机制:一种多组学方法。
Biomedicines. 2022 May 24;10(6):1225. doi: 10.3390/biomedicines10061225.
红细胞储存损伤的性别相关方面。
Blood Transfus. 2021 May;19(3):224-236. doi: 10.2450/2020.0141-20. Epub 2020 Oct 9.
4
Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort.经活检证实的非酒精性脂肪性肝病的死亡率:一项全国性队列研究的结果。
Gut. 2021 Jul;70(7):1375-1382. doi: 10.1136/gutjnl-2020-322786. Epub 2020 Oct 9.
5
Comparison of Erythrocyte Membrane Lipid Profiles between NAFLD Patients with or without Hyperlipidemia.非酒精性脂肪性肝病伴或不伴高脂血症患者红细胞膜脂质谱的比较
Int J Endocrinol. 2020 Sep 16;2020:9501826. doi: 10.1155/2020/9501826. eCollection 2020.
6
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.纤维化分期与非酒精性脂肪性肝病患者结局的相关性:系统评价和荟萃分析。
Gastroenterology. 2020 May;158(6):1611-1625.e12. doi: 10.1053/j.gastro.2020.01.043. Epub 2020 Feb 4.
7
What's new in NAFLD pathogenesis, biomarkers and treatment?非酒精性脂肪性肝病的发病机制、生物标志物及治疗方面有哪些新进展?
Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):70-71. doi: 10.1038/s41575-019-0239-2.
8
Rodent Models of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的啮齿类动物模型。
Digestion. 2020;101(5):522-535. doi: 10.1159/000501851. Epub 2019 Oct 10.
9
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study.非酒精性脂肪性肝病的肝外癌症发病风险高于肥胖症——一项纵向队列研究。
J Hepatol. 2019 Dec;71(6):1229-1236. doi: 10.1016/j.jhep.2019.08.018. Epub 2019 Aug 27.
10
Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.脂肪肝指数(FLI)与非酒精性脂肪性肝病新发病例的预测:伊朗北部的一项基于人群的研究。
Clin Nutr. 2020 Feb;39(2):468-474. doi: 10.1016/j.clnu.2019.02.024. Epub 2019 Mar 18.